IBBQ Holdings — Invesco Nasdaq Biotechnology ETF
All 261 reported holdings of Invesco Nasdaq Biotechnology ETF (IBBQ) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Invesco Private Prime Fund | 14.20% | $9.57M |
| Gilead Sciences, Inc. | 7.39% | $4.98M |
| Vertex Pharmaceuticals Inc. | 7.38% | $4.97M |
| Amgen Inc. | 7.10% | $4.79M |
| Invesco Private Government Fund | 5.48% | $3.69M |
| Regeneron Pharmaceuticals, Inc. | 5.08% | $3.42M |
| Alnylam Pharmaceuticals, Inc. | 3.19% | $2.15M |
| Revolution Medicines, Inc. | 2.48% | $1.67M |
| Biogen Inc. | 2.29% | $1.54M |
| Illumina, Inc. | 1.98% | $1.34M |
| United Therapeutics Corp. | 1.94% | $1.31M |
| Royalty Pharma PLC | 1.90% | $1.28M |
| argenx SE | 1.89% | $1.27M |
| Insmed Inc. | 1.83% | $1.24M |
| Roivant Sciences Ltd. | 1.71% | $1.15M |
| Incyte Corp. | 1.53% | $1.03M |
| Viatris Inc. | 1.49% | $1.00M |
| Moderna, Inc. | 1.48% | $999.15K |
| Guardant Health, Inc. | 1.35% | $911.98K |
| Neurocrine Biosciences, Inc. | 1.26% | $851.81K |
| Jazz Pharmaceuticals PLC | 1.16% | $780.42K |
| Ascendis Pharma A/S | 1.10% | $739.79K |
| Summit Therapeutics Inc. | 1.08% | $729.12K |
| Exelixis, Inc. | 1.04% | $702.83K |
| BridgeBio Pharma, Inc. | 1.02% | $688.64K |
| Medpace Holdings, Inc. | 1.01% | $680.50K |
| Ionis Pharmaceuticals, Inc. | 1.01% | $677.48K |
| Axsome Therapeutics, Inc. | 0.95% | $642.94K |
| Madrigal Pharmaceuticals, Inc. | 0.91% | $611.64K |
| BioMarin Pharmaceutical Inc. | 0.88% | $590.72K |
| BioNTech SE | 0.87% | $586.45K |
| Arrowhead Pharmaceuticals, Inc. | 0.87% | $584.87K |
| Sanofi | 0.85% | $573.04K |
| Praxis Precision Medicines, Inc. | 0.78% | $522.51K |
| Cytokinetics, Inc. | 0.75% | $506.39K |
| BeOne Medicines Ltd. | 0.73% | $493.49K |
| Krystal Biotech, Inc. | 0.72% | $484.25K |
| Tempus AI, Inc. | 0.70% | $470.08K |
| Abivax S.A. | 0.65% | $436.88K |
| Nuvalent, Inc. | 0.64% | $433.06K |
| Halozyme Therapeutics, Inc. | 0.62% | $421.00K |
| ImmunityBio, Inc. | 0.62% | $414.49K |
| Vaxcyte, Inc. | 0.59% | $396.60K |
| Alkermes PLC | 0.56% | $376.93K |
| Immunovant, Inc. | 0.54% | $363.37K |
| Kymera Therapeutics, Inc. | 0.53% | $356.38K |
| Protagonist Therapeutics, Inc. | 0.51% | $340.59K |
| Mirum Pharmaceuticals, Inc. | 0.49% | $328.35K |
| PTC Therapeutics, Inc. | 0.49% | $327.38K |
| Rhythm Pharmaceuticals, Inc. | 0.48% | $323.34K |
| Spyre Therapeutics, Inc. | 0.46% | $309.21K |
| Cogent Biosciences, Inc. | 0.45% | $304.22K |
| CRISPR Therapeutics AG | 0.43% | $288.54K |
| CG Oncology, Inc. | 0.42% | $281.99K |
| Scholar Rock Holding Corp. | 0.40% | $269.08K |
| Centessa Pharmaceuticals PLC | 0.38% | $254.50K |
| Caris Life Sciences, Inc. | 0.37% | $252.32K |
| Ligand Pharmaceuticals Inc. | 0.37% | $247.97K |
| Xenon Pharmaceuticals Inc. | 0.36% | $243.82K |
| Indivior Pharmaceuticals, Inc. | 0.36% | $241.23K |
| Apogee Therapeutics, Inc. | 0.36% | $240.92K |
| Travere Therapeutics, Inc. | 0.35% | $233.40K |
| Amneal Pharmaceuticals, Inc. | 0.33% | $222.09K |
| Twist Bioscience Corp. | 0.33% | $219.80K |
| Erasca, Inc. | 0.32% | $213.11K |
| NewAmsterdam Pharma Co. N.V. | 0.31% | $207.84K |
| Crinetics Pharmaceuticals, Inc. | 0.30% | $199.54K |
| Acadia Pharmaceuticals Inc. | 0.29% | $198.06K |
| Veracyte, Inc. | 0.29% | $197.41K |
| Edgewise Therapeutics, Inc. | 0.29% | $196.45K |
| Beam Therapeutics Inc. | 0.27% | $179.83K |
| Denali Therapeutics Inc. | 0.27% | $178.88K |
| 10x Genomics, Inc. | 0.27% | $178.58K |
| Dyne Therapeutics, Inc. | 0.25% | $170.63K |
| Structure Therapeutics Inc. | 0.24% | $164.28K |
| Tango Therapeutics Inc. | 0.24% | $158.70K |
| Oruka Therapeutics, Inc. | 0.23% | $151.89K |
| GRAIL, Inc. | 0.22% | $150.10K |
| Alumis Inc. | 0.22% | $146.40K |
| Arcutis Biotherapeutics, Inc. | 0.21% | $142.71K |
| Disc Medicine, Inc. | 0.21% | $142.34K |
| Supernus Pharmaceuticals, Inc. | 0.21% | $141.96K |
| IDEAYA Biosciences, Inc. | 0.21% | $138.74K |
| Vera Therapeutics, Inc. | 0.20% | $135.86K |
| Tarsus Pharmaceuticals, Inc. | 0.20% | $135.55K |
| Relay Therapeutics, Inc. | 0.20% | $134.63K |
| Mineralys Therapeutics, Inc. | 0.20% | $133.65K |
| Definium Therapeutics, Inc. | 0.19% | $129.30K |
| Enliven Therapeutics, Inc. | 0.19% | $125.91K |
| Adaptive Biotechnologies Corp. | 0.19% | $125.06K |
| Ultragenyx Pharmaceutical Inc. | 0.18% | $124.01K |
| Legend Biotech Corp. | 0.18% | $122.90K |
| Kodiak Sciences Inc. | 0.18% | $120.15K |
| BioCryst Pharmaceuticals, Inc. | 0.18% | $119.80K |
| Kiniksa Pharmaceuticals International, PLC | 0.18% | $119.06K |
| Aurinia Pharmaceuticals Inc. | 0.16% | $109.29K |
| Ocular Therapeutix, Inc. | 0.16% | $105.16K |
| Pharvaris N.V. | 0.15% | $103.84K |
| NovoCure Ltd. | 0.15% | $103.47K |
| Sionna Therapeutics, Inc. | 0.15% | $102.47K |
| ADMA Biologics, Inc. | 0.15% | $101.89K |
| Rapport Therapeutics, Inc. | 0.15% | $101.67K |
| Zymeworks Inc. | 0.15% | $100.24K |
| AbCellera Biologics Inc. | 0.15% | $100.28K |
| Recursion Pharmaceuticals, Inc. | 0.15% | $99.82K |
| Sarepta Therapeutics, Inc. | 0.15% | $99.84K |
| Harmony Biosciences Holdings, Inc. | 0.14% | $97.39K |
| Nurix Therapeutics, Inc. | 0.14% | $97.41K |
| Trevi Therapeutics, Inc. | 0.14% | $96.58K |
| Novavax, Inc. | 0.14% | $95.82K |
| Tyra Biosciences, Inc. | 0.14% | $95.59K |
| uniQure N.V. | 0.14% | $95.29K |
| Stoke Therapeutics, Inc. | 0.14% | $95.20K |
| ANI Pharmaceuticals, Inc. | 0.14% | $94.37K |
| Syndax Pharmaceuticals, Inc. | 0.14% | $92.64K |
| Agios Pharmaceuticals, Inc. | 0.14% | $91.73K |
| Genmab A/S | 0.13% | $90.39K |
| Iovance Biotherapeutics, Inc. | 0.13% | $90.22K |
| Vericel Corp. | 0.13% | $90.09K |
| Intellia Therapeutics, Inc. | 0.13% | $88.43K |
| AtaiBeckley Inc. | 0.13% | $87.69K |
| Taysha Gene Therapies Inc. | 0.13% | $85.74K |
| Innoviva, Inc. | 0.13% | $85.06K |
| Amylyx Pharmaceuticals, Inc. | 0.13% | $84.77K |
| AnaptysBio, Inc. | 0.12% | $82.61K |
| Precigen, Inc. | 0.12% | $82.04K |
| Inhibrx Biosciences, Inc. | 0.12% | $80.82K |
| Monte Rosa Therapeutics, Inc. | 0.12% | $80.10K |
| Ardelyx, Inc. | 0.12% | $79.87K |
| Vir Biotechnology, Inc. | 0.12% | $79.89K |
| GH Research PLC | 0.12% | $79.77K |
| Fortrea Holdings Inc. | 0.11% | $77.15K |
| MBX Biosciences, Inc. | 0.11% | $75.75K |
| KalVista Pharmaceuticals, Inc. | 0.11% | $73.52K |
| Bicara Therapeutics Inc. | 0.11% | $73.52K |
| Septerna, Inc. | 0.11% | $71.66K |
| UroGen Pharma Ltd. | 0.10% | $70.58K |
| Harrow, Inc. | 0.10% | $69.36K |
| Maze Therapeutics, Inc. | 0.10% | $68.27K |
| Immunocore Holdings PLC | 0.10% | $67.92K |
| ArriVent Biopharma, Inc. | 0.10% | $66.62K |
| Wave Life Sciences Ltd. | 0.10% | $66.41K |
| COMPASS Pathways PLC | 0.10% | $66.03K |
| Personalis, Inc. | 0.09% | $63.03K |
| MannKind Corp. | 0.09% | $62.27K |
| EyePoint, Inc. | 0.09% | $60.27K |
| Alvotech | 0.09% | $59.50K |
| Savara Inc. | 0.08% | $56.72K |
| Collegium Pharmaceutical, Inc. | 0.08% | $56.63K |
| Olema Pharmaceuticals, Inc. | 0.08% | $56.47K |
| Corvus Pharmaceuticals, Inc. | 0.08% | $54.94K |
| Xeris Biopharma Holdings, Inc. | 0.08% | $54.79K |
| AbSci Corp. | 0.08% | $54.72K |
| Zenas Biopharma, Inc. | 0.08% | $52.96K |
| Cullinan Therapeutics, Inc. | 0.08% | $52.07K |
| Grifols, S.A. | 0.08% | $51.34K |
| Pacira Biosciences, Inc. | 0.07% | $49.85K |
| ARS Pharmaceuticals, Inc. | 0.07% | $48.35K |
| Sana Biotechnology, Inc. | 0.07% | $47.42K |
| Arbutus Biopharma Corp. | 0.07% | $47.02K |
| Janux Therapeutics, Inc. | 0.07% | $46.88K |
| Kura Oncology, Inc. | 0.07% | $46.89K |
| Xencor, Inc. | 0.07% | $46.71K |
| MeiraGTx Holdings PLC | 0.07% | $45.95K |
| Amphastar Pharmaceuticals, Inc. | 0.07% | $45.81K |
| ORIC Pharmaceuticals, Inc. | 0.07% | $44.82K |
| Theravance Biopharma Inc. | 0.06% | $43.64K |
| Eton Pharmaceuticals, Inc. | 0.06% | $43.27K |
| Geron Corp. | 0.06% | $42.78K |
| Mesoblast Ltd. | 0.06% | $42.61K |
| Annexon, Inc. | 0.06% | $42.32K |
| Omeros Corp. | 0.06% | $41.96K |
| Phathom Pharmaceuticals, Inc. | 0.06% | $40.72K |
| BioAge Labs, Inc. | 0.06% | $39.66K |
| Esperion Therapeutics, Inc. | 0.06% | $39.45K |
| Replimune Group, Inc. | 0.06% | $37.91K |
| Maravai LifeSciences Holdings, Inc. | 0.06% | $37.08K |
| CorMedix Inc. | 0.05% | $35.15K |
| Zevra Therapeutics, Inc. | 0.05% | $34.46K |
| Phibro Animal Health Corp. | 0.05% | $33.93K |
| Prime Medicine, Inc. | 0.05% | $33.81K |
| Vor BioPharma Inc. | 0.05% | $33.58K |
| Castle Biosciences, Inc. | 0.05% | $33.01K |
| CytomX Therapeutics, Inc. | 0.05% | $32.15K |
| Candel Therapeutics, Inc. | 0.05% | $32.09K |
| Zai Lab Ltd. | 0.05% | $32.00K |
| Design Therapeutics, Inc. | 0.05% | $31.57K |
| Tectonic Therapeutic, Inc. | 0.05% | $31.16K |
| Ironwood Pharmaceuticals, Inc. | 0.05% | $30.71K |
| Arvinas, Inc. | 0.04% | $30.27K |
| Solid Biosciences Inc. | 0.04% | $30.20K |
| Rigel Pharmaceuticals, Inc. | 0.04% | $29.36K |
| Aclaris Therapeutics, Inc. | 0.04% | $28.96K |
| Prothena Corp. PLC | 0.04% | $28.79K |
| 4D Molecular Therapeutics, Inc. | 0.04% | $26.64K |
| Aquestive Therapeutics, Inc. | 0.04% | $25.89K |
| Kyverna Therapeutics, Inc. | 0.04% | $25.75K |
| Allogene Therapeutics, Inc. | 0.04% | $25.74K |
| Aura Biosciences, Inc. | 0.04% | $24.99K |
| Fulcrum Therapeutics, Inc. | 0.04% | $24.23K |
| Kamada Ltd. | 0.04% | $23.85K |
| Neurogene Inc. | 0.04% | $23.78K |
| Pacific Biosciences of California, Inc. | 0.04% | $23.74K |
| Upstream Bio, Inc. | 0.04% | $23.74K |
| First Tracks Biotherapeutics, Inc. | 0.03% | $23.49K |
| Lakefront Biotherapeutics N.V. | 0.03% | $22.51K |
| Evolus, Inc. | 0.03% | $22.45K |
| C4 Therapeutics, Inc. | 0.03% | $22.46K |
| Contineum Therapeutics, Inc. | 0.03% | $21.69K |
| OmniAb, Inc. | 0.03% | $20.47K |
| Altimmune, Inc. | 0.03% | $20.16K |
| Enanta Pharmaceuticals, Inc. | 0.03% | $20.07K |
| Vanda Pharmaceuticals Inc. | 0.03% | $20.07K |
| Larimar Therapeutics, Inc. | 0.03% | $19.96K |
| Lexeo Therapeutics, Inc. | 0.03% | $19.79K |
| Autolus Therapeutics PLC | 0.03% | $19.78K |
| Immuneering Corp. | 0.03% | $19.66K |
| Lyell Immunopharma, Inc. | 0.03% | $19.39K |
| Atea Pharmaceuticals, Inc. | 0.03% | $19.27K |
| Cabaletta Bio, Inc. | 0.03% | $19.21K |
| Puma Biotechnology, Inc. | 0.03% | $19.22K |
| REGENXBIO Inc. | 0.03% | $18.68K |
| Keros Therapeutics, Inc. | 0.03% | $18.11K |
| Editas Medicine, Inc. | 0.03% | $17.79K |
| SIGA Technologies, Inc. | 0.03% | $17.64K |
| Rocket Pharmaceuticals, Inc. | 0.03% | $17.61K |
| Silence Therapeutics PLC | 0.03% | $17.08K |
| Invivyd, Inc. | 0.02% | $16.65K |
| Neumora Therapeutics, Inc. | 0.02% | $16.30K |
| Alpha Teknova, Inc. | 0.02% | $15.25K |
| Anavex Life Sciences Corp. | 0.02% | $14.78K |
| Entrada Therapeutics, Inc. | 0.02% | $14.26K |
| AC Immune S.A. | 0.02% | $14.13K |
| Codexis, Inc. | 0.02% | $13.20K |
| Foghorn Therapeutics Inc. | 0.02% | $13.19K |
| Humacyte, Inc. | 0.02% | $13.23K |
| LENZ Therapeutics, Inc. | 0.02% | $12.90K |
| Coherus Oncology, Inc. | 0.02% | $12.53K |
| Quantum-Si Inc. | 0.02% | $12.26K |
| Voyager Therapeutics, Inc. | 0.02% | $12.00K |
| Sagimet Biosciences Inc. | 0.02% | $11.96K |
| Arcturus Therapeutics Holdings Inc. | 0.02% | $11.79K |
| Caribou Biosciences, Inc. | 0.02% | $11.62K |
| Orchestra Biomed Holdings, Inc. | 0.02% | $11.66K |
| Bicycle Therapeutics PLC | 0.02% | $11.44K |
| NovaBridge Biosciences | 0.02% | $10.90K |
| Lifecore Biomedical, Inc. | 0.01% | $9.88K |
| Tenaya Therapeutics, Inc. | 0.01% | $9.92K |
| Jyong Biotech Ltd. | 0.01% | $8.63K |
| Black Diamond Therapeutics, Inc. | 0.01% | $6.69K |
| Pyxis Oncology, Inc. | 0.01% | $5.90K |
| PepGen Inc. | 0.01% | $5.44K |
| Invesco Government & Agency Portfolio | 0.01% | $5.40K |
| Rani Therapeutics Holdings, Inc. | 0.01% | $4.89K |
| Aardvark Therapeutics, Inc. | 0.01% | $4.73K |
| Gossamer Bio, Inc. | 0.00% | $2.82K |
| Cartesian Therapeutics, Inc. | 0.00% | $359 |
| Novo Nordisk A/S | 0.00% | $0 |
| OmniAb, Inc. | 0.00% | $0 |
| Third Harmonic Bio, Inc. | 0.00% | $0 |
| OmniAb, Inc. | 0.00% | $0 |
IBBQ overview: performance, fees, allocation and SEC filings